Viewing Study NCT05087602


Ignite Creation Date: 2025-12-25 @ 3:56 AM
Ignite Modification Date: 2025-12-26 @ 2:46 AM
Study NCT ID: NCT05087602
Status: UNKNOWN
Last Update Posted: 2021-10-21
First Post: 2021-10-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Toripalimab Combined With Anlotinib in Unresectable Locally Advanced or Metastatic Acral Malignant Melanoma
Sponsor: Qilu Hospital of Shandong University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module